Free Trial
NASDAQ:CYTHW

Cyclo Therapeutics (CYTHW) Stock Price, News & Analysis

$0.03 0.00 (0.00%)
As of 03/26/2025

About Cyclo Therapeutics Stock (NASDAQ:CYTHW)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.30
52-Week Range
$0.03
$0.61
Volume
N/A
Average Volume
17,370 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company's lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer's disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida.

Remove Ads
Receive CYTHW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyclo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CYTHW Stock News Headlines

See More Headlines

CYTHW Stock Analysis - Frequently Asked Questions

Cyclo Therapeutics' stock was trading at $0.1225 on January 1st, 2025. Since then, CYTHW stock has decreased by 73.9% and is now trading at $0.0320.
View the best growth stocks for 2025 here
.

Shares of CYTHW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CYTHW
Web
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$870,725.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:CYTHW) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners